TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34863358

Group type: EXPERIMENTAL
Intervention: mRNA1273 (Moderna)
Number of subjects: 2878

Group type: EXPERIMENTAL
Intervention: Ad26.COV2.S (Janssen)
Number of subjects: 2878

Group type: EXPERIMENTAL
Intervention: half VLA (Valneva)
Number of subjects: 2878

Group type: COMPARATOR
Intervention: Control (MenACWY)
Number of subjects: 2878

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCov-19 (Oxford-AstraZeneca)
Number of subjects: 2878

Group type: EXPERIMENTAL
Intervention: BNT162b2 (Pfizer-BioNtech)
Number of subjects: 2878
Study: 34254530

Group type: EXPERIMENTAL
Intervention: Intensified induction with high-doses cytarabine (1500 mg/m2 b.i.d. on days 5-7 of induction)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (not specified)
Number of subjects: 0
Study: 34508370

Group type: EXPERIMENTAL
Intervention: Convalescent plasma (CP) transfusion
Number of subjects: 34
Study: 36275698

Group type: EXPERIMENTAL
Intervention: TMPs‐MTX (intrapleural infusion of tumor cell-derived microparticles packaging methotrexate)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: TMPs‐MTX
Number of subjects: 86

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: TMPs‐MTX and Saline (both groups)
Number of subjects: 86
Study: 34588689

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV‐19 (AZD1222) vaccine
Number of subjects: 264
Study: 35100251

Group type: EXPERIMENTAL
Intervention: Wang Nam Yen herbal tea
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 32008913

Group type: EXPERIMENTAL
Intervention: Fatty fish (∼630 g/week)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Nuts (∼200 g/week)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control group (usual diet, restricting fatty fish and nuts)
Number of subjects: 131
Study: 36171614

Group type: EXPERIMENTAL
Intervention: Community and Provider driven Social Accountability Intervention (CaPSAI)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 33427674

Group type: EXPERIMENTAL
Intervention: Cultivation process intervention
Number of subjects: 1240

Group type: EXPERIMENTAL
Intervention: Self-efficacy enhancement first (cultivation process)
Number of subjects: 1240

Group type: COMPARATOR
Intervention: Social support only
Number of subjects: 1240
Study: 35322650

Group type: EXPERIMENTAL
Intervention: Axial Digital Impression Group (ADIG)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Axial Conventional Impression Group (ACIG)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Tilted Digital Impression Group (TDIG)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Tilted Conventional Impression Group (TCIG)
Number of subjects: 56
Study: 34558247

Group type: EXPERIMENTAL
Intervention: Moxibustion therapy (20 minutes, once every other day for 8 weeks)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Donepezil hydrochloride tablets (5 mg once a day for 8 weeks)
Number of subjects: 120
Study: 33331989

Group type: EXPERIMENTAL
Intervention: Dacomitinib 45 mg/day
Number of subjects: 452

Group type: COMPARATOR
Intervention: Gefitinib 250 mg/day
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Dacomitinib with dose reduction(s)
Number of subjects: 452
Study: 32964776

Group type: EXPERIMENTAL
Intervention: Active stimulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study: 34338309

Group type: EXPERIMENTAL
Intervention: Piezoelectric 11 Gracey curet tip
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Gracey curet
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Piezoelectric scaler
Number of subjects: 4

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 4
Study: 34086033

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT)
Number of subjects: 4781

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 4781

Group type: EXPERIMENTAL
Intervention: DAPT
Number of subjects: 4781
Study: 32731987

Group type: COMPARATOR
Intervention: Positive Control (PC)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Negative Control (NC)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Phytase A (250, 500, 750, 1,000 FTU/kg)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Phytase B (250, 500, 750 FTU/kg)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Phytase C (500, 750, 1,000 FTU/kg)
Number of subjects: 300
Study: 35438304

Group type: EXPERIMENTAL
Intervention: Intravenous (IV) delta-9 tetrahydrocannabinol (THC) at 0.015 mg/kg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Intravenous (IV) delta-9 tetrahydrocannabinol (THC) at 0.03 mg/kg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Intravenous (IV) placebo
Number of subjects: 42
Study: 33618930

Group type: EXPERIMENTAL
Intervention: Brief intervention
Number of subjects: 524

Group type: COMPARATOR
Intervention: Usual advice
Number of subjects: 524
Study: 32771013

Group type: EXPERIMENTAL
Intervention: rhEPO (500 IU/kg intravenously every other day for 2 weeks)
Number of subjects: 1285
Study: 35667722

Group type: EXPERIMENTAL
Intervention: Unattended office BP measurement
Number of subjects: 630

Group type: COMPARATOR
Intervention: Attended office BP measurement
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Home BP monitoring (HBPM) for sleep BP
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Sleep BP on HBPM
Number of subjects: 630
Study: 34627009

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (800 mg daily)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 32334578

Group type: EXPERIMENTAL
Intervention: Fear of movement
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Pain catastrophizing
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 167
Study: 33899261

Group type: EXPERIMENTAL
Intervention: Shared oral care intervention
Number of subjects: 243

Group type: COMPARATOR
Intervention: Standard oral care programme (Control)
Number of subjects: 243
Study: 32000738

Group type: EXPERIMENTAL
Intervention: Enhanced group (culturally tailored diabetes prevention program addressing psychosocial stressors)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Standard group (culturally tailored diabetes prevention program)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 207
Study: 36324443

Group type: EXPERIMENTAL
Intervention: Nomogram based on multivariate Cox regression model to predict cancer-specific survival (CSS)
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: Nomogram based on multivariate Cox regression model to predict CSS
Number of subjects: 619
Study: 33452773

Group type: EXPERIMENTAL
Intervention: Suctioning first
Number of subjects: 154

Group type: COMPARATOR
Intervention: Drying first
Number of subjects: 154
Study: 34034603

Group type: EXPERIMENTAL
Intervention: PFMT with psychologist (n = 41)
Number of subjects: 88

Group type: COMPARATOR
Intervention: PFMT treatment as usual (n = 47)
Number of subjects: 88
Study: 33180967

Group type: EXPERIMENTAL
Intervention: Dental Operating Microscope (DOM)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Dental Loupes
Number of subjects: 17

Group type: COMPARATOR
Intervention: No Magnification (Control)
Number of subjects: 17
Study: 34580881

Group type: EXPERIMENTAL
Intervention: Writing group (traced characters on paper with a ballpoint pen for 15 min/day for 10 days)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Peg group (used a pegboard for 15 min/day for 10 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 32763103

Group type: EXPERIMENTAL
Intervention: Provision of a copy of the patient's medical notes on admission and discharge, along with a plain English statement about their medical condition and a detailed care plan.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard care (verbal information)
Number of subjects: 200
Study: 35589346

Group type: EXPERIMENTAL
Intervention: Boys (neonates)
Number of subjects: 59729

Group type: COMPARATOR
Intervention: Girls (neonates)
Number of subjects: 59729
Study: 32648072

Group type: COMPARATOR
Intervention: Patiromer
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Spironolactone with Patiromer
Number of subjects: 295
Study: 34530172

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study: 33672073

Group type: EXPERIMENTAL
Intervention: Conventional Diet
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD) - high meal frequency
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD) - physical activity
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Energy expenditure interventions
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Increased albuminuria
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: eGFR
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Energy expenditure increase (400 kcal/70 kg)
Number of subjects: 128
Study: 36100886

Group type: EXPERIMENTAL
Intervention: T-piece device with a PIP of 30 cmH2O and positive end-expiratory airway pressure of 5 cmH2O
Number of subjects: 23
Study: 34039406

Group type: EXPERIMENTAL
Intervention: Individualized, low-cost, and accessible pulmonary rehabilitation program with weekly physiotherapist supervision
Number of subjects: 50

Group type: COMPARATOR
Intervention: Individualized, low-cost, and accessible pulmonary rehabilitation program without weekly physiotherapist supervision
Number of subjects: 50
Study: 34182829

Group type: EXPERIMENTAL
Intervention: DLMOff model
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: DLMO model
Number of subjects: 16
Study: 34290290

Group type: EXPERIMENTAL
Intervention: Smoking initiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control for genetic influences on covariates (cannabis and alcohol use, risk‐taking, insomnia)
Number of subjects: 0
Study: 34108383

Group type: EXPERIMENTAL
Intervention: Maternal ART (mART)
Number of subjects: 2431

Group type: COMPARATOR
Intervention: Infant nevirapine prophylaxis (iNVP)
Number of subjects: 2431
Study: 32386593

Group type: EXPERIMENTAL
Intervention: Secukinumab (300 mg subcutaneously at baseline, weeks 1, 2, 3, and 4, then every 4 weeks until week 48)
Number of subjects: 853

Group type: COMPARATOR
Intervention: Adalimumab (40 mg every 2 weeks from baseline until week 50)
Number of subjects: 853

Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 853

Group type: COMPARATOR
Intervention: Adalimumab
Number of subjects: 853
Study: 34896242

Group type: EXPERIMENTAL
Intervention: PRP injection in the healing edge and the floor of the targeted DFU (Group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual standard care with moist dressing with or without collagenase ointment (Group B)
Number of subjects: 80
Study: 35183373

Group type: EXPERIMENTAL
Intervention: Intravenous golimumab 2 mg/kg every 6 weeks (Q6W)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous golimumab 2 mg/kg every 8 weeks (Q8W)
Number of subjects: 0
Study: 32873957

Group type: EXPERIMENTAL
Intervention: Alkaline supplementation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Protein-rich diet
Number of subjects: 40
Study: 36201327

Group type: EXPERIMENTAL
Intervention: Proactive Health Support (PaHS) - telephone-based self-management support
Number of subjects: 6402

Group type: COMPARATOR
Intervention: Usual universal tax-funded healthcare
Number of subjects: 6402
Study: 34008842

Group type: EXPERIMENTAL
Intervention: 900 μg vitamin D3
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 900 μg 25(OH)D3
Number of subjects: 16
Study: 32946353

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg every 3 weeks for 1 year)
Number of subjects: 1019

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1019
Study: 33538956

Group type: EXPERIMENTAL
Intervention: MyPath (intervention group)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study: 33376581

Group type: EXPERIMENTAL
Intervention: Fasting-mimicking diet with low energy-specific meal replacement meals
Number of subjects: 100

Group type: COMPARATOR
Intervention: Specific meal replacement foods given normal adult doses
Number of subjects: 100
Study: 36418984

Group type: EXPERIMENTAL
Intervention: Standard of care + three units of high‐titre convalescent plasma
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Standard of care + three units of standard plasma
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 180
Study: 32189227

Group type: EXPERIMENTAL
Intervention: Improvisational music therapy
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Attunement observed from session videos
Number of subjects: 101
Study: 35090722

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 100 μg
Number of subjects: 290

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 290
Study: 34686365

Group type: EXPERIMENTAL
Intervention: ABCD 3 mg/kg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ABCD 4 mg/kg
Number of subjects: 30
Study: 35580819

Group type: EXPERIMENTAL
Intervention: Intrinsic reward (same-day)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Anticipated regret (same-day)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Self-efficacy (same-day)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Intrinsic reward (between-level)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Anticipated regret (between-level)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Self-efficacy (between-level)
Number of subjects: 135
Study: 34087877

Group type: EXPERIMENTAL
Intervention: Rational emotive career education program (12 sessions)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Waitlisted control group (no intervention)
Number of subjects: 61
Study: 32418375

Group type: EXPERIMENTAL
Intervention: Cesarean section
Number of subjects: 1040
Study: 34107477

Group type: EXPERIMENTAL
Intervention: HA380 hemoperfusion cartridge (HP group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional CPB circuit (Control group)
Number of subjects: 60
Study: 32444570

Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (RAGT) alongside conventional physiotherapy (30 min/session each, total 60 min/session, 3-4 sessions/week for 30 sessions over 8-10 weeks)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (RAGT) alongside conventional physiotherapy
Number of subjects: 75
Study: 35643360

Group type: EXPERIMENTAL
Intervention: Calorie Restricted (CR) diet
Number of subjects: 88
Study: 32757311

Group type: EXPERIMENTAL
Intervention: Socket shield technique with immediate temporization
Number of subjects: 40

Group type: COMPARATOR
Intervention: Immediate implant placement with immediate temporization
Number of subjects: 40
Study: 33137754

Group type: EXPERIMENTAL
Intervention: Dexterity Network (Dex-Net) 4.0 policy using ambidextrous grippers
Number of subjects: 1
Study: 33501773

Group type: EXPERIMENTAL
Intervention: Consent to randomization in AALL0932
Number of subjects: 0
Study: 32203692

Group type: EXPERIMENTAL
Intervention: Guselkumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36038164

Group type: EXPERIMENTAL
Intervention: SBRT with BED10 of 60-70 Gy combined with gemcitabine plus albumin-bound paclitaxel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SBRT with BED10 >70 Gy combined with gemcitabine plus albumin-bound paclitaxel
Number of subjects: 0
Study: 33835198

Group type: EXPERIMENTAL
Intervention: Sports compression garment (CG) (28.6 ± 9.4 mmHg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Gymnastic pants (CON)
Number of subjects: 13
Study: 35932279

Group type: EXPERIMENTAL
Intervention: STRIDE intervention (multifactorial intervention delivered by trained registered nurses)
Number of subjects: 5451

Group type: EXPERIMENTAL
Intervention: STRIDE intervention
Number of subjects: 5451
Study: 35938328

Group type: EXPERIMENTAL
Intervention: Acupuncture at Sanyinjiao (SP 6) and Guanyuan (CV 4), once a day starting 5-7 days before menstrual flow for 3 menstrual cycles.
Number of subjects: 42

Group type: COMPARATOR
Intervention: No intervention (control group).
Number of subjects: 42
Study: 33833857

Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) treatment
Number of subjects: 0
Study: 32015684

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (GBE)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 35895484

Group type: EXPERIMENTAL
Intervention: Fractional flow reserve-guided percutaneous coronary intervention with new-generation drug-eluting stents
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Coronary bypass surgery
Number of subjects: 1500
Study: 34577457

Group type: EXPERIMENTAL
Intervention: Garmin Vivoactive 4s
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Garmin Vivosport
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Polar Vantage M
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: All trackers
Number of subjects: 28
Study: 33040112

Group type: EXPERIMENTAL
Intervention: Endotracheal intubation with Miller blade in E+ group (oesophageal intubation simulated)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Endotracheal intubation with Miller blade in E- group (standard procedure)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Endotracheal intubation with Macintosh blade in E+ group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Endotracheal intubation with Macintosh blade in E- group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Endotracheal intubation with video laryngoscope in E+ group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Endotracheal intubation with video laryngoscope in E- group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Degree of task difficulty for both groups (E+ and E-)
Number of subjects: 120
Study: 34169482

Group type: EXPERIMENTAL
Intervention: Oropharyngeal exercise (OPE) in addition to CPAP therapy
Number of subjects: 41
Study: 35000358

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided infraclavicular block (IB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Procedural sedation and analgesia (PSA)
Number of subjects: 60
Study: 34185862

Group type: EXPERIMENTAL
Intervention: Simulation-based medical emergency preparedness curriculum
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard curriculum
Number of subjects: 16
Study: 35113938

Group type: EXPERIMENTAL
Intervention: Physical exercise (aerobic and resistance training) for 12 weeks
Number of subjects: 38
Study: 33294966

Group type: EXPERIMENTAL
Intervention: Attachment-theory-informed psychotherapeutic intervention
Number of subjects: 0
Study: 34860575

Group type: EXPERIMENTAL
Intervention: Multitiered system of language support (MTSLS) using Story Champs for 14 weeks, with Tier 1 instruction for 15-20 min a day for 4 weeks followed by Tier 2 intervention for 20 min twice a week for students who did not make adequate progress.
Number of subjects: 686

Group type: EXPERIMENTAL
Intervention: Tier 2 intervention of Story Champs for at-risk students (n = 49)
Number of subjects: 686
Study: 33417506

Group type: EXPERIMENTAL
Intervention: eRAPID (weekly online symptom reporting for 18 weeks)
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: eRAPID
Number of subjects: 508

Group type: COMPARATOR
Intervention: usual care (UC)
Number of subjects: 508
Study: 32224483

Group type: EXPERIMENTAL
Intervention: iCAN‐DO internet-based stepped care program
Number of subjects: 15
Study: 36493386

Group type: EXPERIMENTAL
Intervention: 10 mg THC + 0 mg CBD
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 10 mg THC + 10 mg CBD
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 10 mg THC + 20 mg CBD
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 10 mg THC + 30 mg CBD
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (0 mg THC and CBD)
Number of subjects: 46
Study: 34080015

Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine (NAC)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine (NAC) + Environmental Enrichment (EE)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 32289634

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (200,000 IU for the first 2 months, then 100,000 IU monthly for 18 months)
Number of subjects: 313

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 313
Study: 34788380

Group type: EXPERIMENTAL
Intervention: Healthy individuals
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Mechanically ventilated patients
Number of subjects: 39
Study: 33167092

Group type: EXPERIMENTAL
Intervention: TRXR1 siRNA interference group 1 (transfected with TRXR1‐siRNA1)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: TRXR1 siRNA interference group 2 (transfected with TRXR1‐siRNA2)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Negative control group (transfected with NC‐siRNA)
Number of subjects: 76
Study: 35531965

Group type: EXPERIMENTAL
Intervention: Symbol Digit Modalities Test (SDMT)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: SDMT z score
Number of subjects: 275
Study: 33069623

Group type: EXPERIMENTAL
Intervention: One-stage BMGU
Number of subjects: 135
Study: 35152915

Group type: EXPERIMENTAL
Intervention: Phantom motor execution (PME)
Number of subjects: 67
Study: 33388032

Group type: EXPERIMENTAL
Intervention: Single general practice attendance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multiple general practice attendance
Number of subjects: 0
Study: 35426283

Group type: EXPERIMENTAL
Intervention: Low-dose TXA (20 mg/kg)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: High-dose TXA (50 mg/kg)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo-controlled (normal saline)
Number of subjects: 116
Study: 34003418

Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention
Number of subjects: 409
Study: 33071253

Group type: EXPERIMENTAL
Intervention: Coelioscopic‐assisted ovariosalpingectomy using a digital otoscope (right prefemoral access)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Coelioscopic‐assisted ovariosalpingectomy using a digital otoscope (left prefemoral access)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Coelioscopic‐assisted ovariosalpingectomy using a digital otoscope (both groups)
Number of subjects: 20